Medical Health & Life Science Research News

Research report explores the global extracorporeal membrane oxygenation machine market to 2021

The extracorporeal membrane oxygenation machine market is expected to witness the highest growth in the Asia-Pacific region, with emphasis on China, Japan, India, and the Rest of Asia-Pacific in the forecast period. The extracorporeal membrane oxygenation machine market is poised to reach USD 305.3 million by 2021 from USD 247.2 million in 2016, at a CAGR of 4.3%. Learn details of the Top Company Profile, Future Trends and Regional Analysis

- Agency -.

The report "Extracorporeal Membrane Oxygenation Machine Market” Analysis & Forecasts to 2021", that analyzes and studies the major market drivers, restraints/challenges, and opportunities. Browse 78 market data tables and 31 figures spread through 129 pages and in-depth TOC on "Extracorporeal Membrane Oxygenation Machine Market”

Complete report on Extracorporeal Membrane Oxygenation Machine Market spread across 129 Pages, Profiling 11 Companies and Supported with 78 Tables and 31 Figures is now available at www.rnrmarketresearch.com/extracorporeal-membrane-oxygenation-ecmo-systems-market-by-modality-veno-arterial-va-veno-venous-vv-arterio-venous-av-by-application-respiratory-cardiac-ecpr-by-geography-global-forecast-to-2020-market-report.html .

North America is estimated to account for the largest share of the Extracorporeal Membrane Oxygenation Machine market, followed by Europe. The favorable reimbursement scenario, rising incidence of lung cancer, and the presence of a large number of ECMO centers in the U.S.

- Agency -.

is expected to boost the market for ECMO systems in North America. A majority of the leading players in the market are pursuing the strategies of approvals, product launches, agreements & partnerships, expansions, and other strategies (rebranding, acquisition, website launch, product development, and market deployment).

Target Audience: 

  • ECMO Systems and related devices manufacturing companies
  • Suppliers and distributors of ECMO systems and components
  • Hospitals, ECMO centers, and medical colleges
  • Teaching hospitals and academic medical centers (AMCs)
  • Government bodies and regulatory authorities
  • Business research and consulting service providers
  • Venture capitalists

Factors such as favorable reimbursement scenario in Japan, rising cardiovascular diseases in China, growing application and adoption of extracorporeal membrane oxygenation machine in India, and rising cardiopulmonary disorders in Australia are driving the growth of the market in this region.

Report:

www.rnrmarketresearch.com/contacts/request-sample?rname=444047 .

North America expected to account for largest share of global market in 2016, followed by Europe, Asia-Pacific, & Rest of the World (RoW). Large share of North American region can be attributed to the favorable reimbursement scenario, rising incidence of lung cancer, & presence of a large number of ECMO centers in U.S.

Factors such as growing cardiovascular & respiratory diseases, rising adoption of ECMO as a bridge to lung transplantation, growing number of ECMO centers, conferences & training programs to increase awareness, and technological advancements have led to growth of market.

Key players of extracorporeal membrane oxygenation machine market were Getinge Group (Sweden), Medtronic plc (Ireland), and LivaNova PLC (U.K.). These companies together contributed 68.8% of the global market in 2015.

The other players of the market are XENIOS AG (Germany), Terumo Corporation (Japan), MicroPort Scientific Corporation (China), NIPRO Corporation (Japan), OriGen Biomedical, Inc. (U.S.), ALung Technologies, Inc.

(Germany), and EUROSETS S.r.l. (Italy).

Report: www.rnrmarketresearch.com/contacts/?rname=444047 .

Extracorporeal membrane oxygenation machine market report segments the market based on modality, application, and region. On the basis of modality, the market is segmented into venoarterial (VA), venovenous (VV), and arteriovenous (AV).

The venovenous (VV) segment is expected to account for the largest share of the market in 2016. The large share of this segment is mainly attributed to the high incidence of respiratory failure, rising lung transplants, and technological advancements.

The arteriovenous (AV) segment is projected to grow at the highest CAGR in the forecast period.

News From

RnR Market Research - Market Research and Competitive Analysis ReportsRnR Market Research
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.